Evaluation of the Ki-67 Proliferation Index and Urocortin Expression in Women with Ovarian Endometriomas

Overview

Journal Eurasian J Med

Publisher Aves

Specialty General Medicine

Date 2017 Jun 23

PMID 28638252

Citations 7

Authors

Serenat Eris Yalcin

Irfan Ocal

Yakup Yalcin

Halime Sen Selim

Melike Demir Caltekin

Huseyin Aydogmus

Sefa Kelekci

Affiliations

Soon will be listed here.

Abstract

Objective: The reasons why endometriosis is more aggressive and invasive in some patients are unknown. Despite the importance of population-based clinically defined risk factors in the prediction of recurrence, biochemical markers obtained from the patient are more valuable for prediction on an individual basis. Therefore, the discovery of significant potential biomarkers could be useful to clinicians for shedding light on the pathogenesis of endometriosis and in the monitoring recurrence.

Materials And Methods: This study included 50 patients who underwent surgery for ovarian cysts that were diagnosed as endometrioma. The age of the patients, stage of the endometriosis, diameter and localization of endometriomas, type of surgery, and pre- and postoperative cancer antigen 125 (CA125) levels were compared between patients with and without recurrence. The archived pathology slides were stained with Ki-67 and anti-urocortin antibodies for reevaluation. By comparing the pathology parameters of the patients with and without recurrence, the association between these parameters and recurrence was investigated.

Results: The median Ki-67 proliferation index of the patients with recurrence (7.5±6.5) was statistically significant compared with that of the patients without recurrence (1±4) (p=0.003). The urocortin epithelial staining intensity and percentage were not found to be statistically significant in comparison. A statistically significant difference was determined between postoperative CA125 median levels of patients without recurrence (10±17.6) and those of patients with recurrence (29.9±18.1) (p=0.003).

Conclusion: The Ki-67 proliferation index may be useful for predicting prognosis and recurrence risk.

Citing Articles

Patterns of proliferation and fibrosis in a rat model of endometriosis following administration of Allium cepa.

Kula H, Ilgen O, Kurt S, Yilmaz F Clin Exp Reprod Med. 2024; 51(2):112-119.

PMID: 38263589 PMC: 11140262. DOI: 10.5653/cerm.2023.06261.

Clinicopathological correlations of peritoneal endometriosis and deep infiltrating endometriosis.

Qiu M, Wang Y, Ren R, Sun Y, Xiao S, Han L Ann Med. 2023; 55(2):2244877.

PMID: 37624743 PMC: 10461492. DOI: 10.1080/07853890.2023.2244877.

Possible Correlation between Urocortin 1 (Ucn1) and Immune Parameters in Patients with Endometriosis.

Abramiuk M, Frankowska K, Kulak K, Tarkowski R, Mertowska P, Mertowski S Int J Mol Sci. 2023; 24(9).

PMID: 37175494 PMC: 10178394. DOI: 10.3390/ijms24097787.

The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis.

Kimber-Trojnar Z, Pilszyk A, Niebrzydowska M, Pilszyk Z, Ruszala M, Leszczynska-Gorzelak B J Clin Med. 2021; 10(13).

PMID: 34201813 PMC: 8268879. DOI: 10.3390/jcm10132762.

Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.

Niguez Sevilla I, Machado Linde F, Marin Sanchez M, Arense J, Torroba A, Nieto Diaz A J Gynecol Oncol. 2019; 30(4):e63.

PMID: 31074246 PMC: 6543102. DOI: 10.3802/jgo.2019.30.e63.

References

Novembri R, Borges L, Carrarelli P, Rocha A, de Pascalis F, Florio P . Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. J Clin Endocrinol Metab. 2011; 96(4):1145-50. DOI: 10.1210/jc.2010-2263. View

Nagamani M, Kelver M, Smith E . CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence. Int J Fertil. 1992; 37(4):227-31. View

Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T . Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab. 1999; 84(5):1737-43. DOI: 10.1210/jcem.84.5.5706. View

Reyes T, Lewis K, PERRIN M, Kunitake K, Vaughan J, Arias C . Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A. 2001; 98(5):2843-8. PMC: 30227. DOI: 10.1073/pnas.051626398. View

Fedele L, Arcaini L, Vercellini P, Bianchi S, CANDIANI G . Serum CA 125 measurements in the diagnosis of endometriosis recurrence. Obstet Gynecol. 1988; 72(1):19-22. View

Lewis K, Li C, PERRIN M, Blount A, Kunitake K, Donaldson C . Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A. 2001; 98(13):7570-5. PMC: 34709. DOI: 10.1073/pnas.121165198. View

Toki T, Kubota J, Lu X, Nakayama K . Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation. Acta Obstet Gynecol Scand. 2000; 79(9):771-6. View

Vaughan J, Donaldson C, BITTENCOURT J, PERRIN M, Lewis K, Sutton S . Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 1995; 378(6554):287-92. DOI: 10.1038/378287a0. View

Huisman M, de Heer E, Grote J . Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol. 2003; 123(3):377-82. DOI: 10.1080/00016480310001376. View

10.

Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M . Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol. 2002; 173(2):R9-14. DOI: 10.1677/joe.0.173r009. View

11.

Scotti S, Regidor P, Schindler A, Winterhager E . Reduced proliferation and cell adhesion in endometriosis. Mol Hum Reprod. 2000; 6(7):610-7. DOI: 10.1093/molehr/6.7.610. View

12.

Kim S, Choi Y, Choung S, Jun J, Kim J, Moon S . Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod. 2005; 20(10):2904-8. DOI: 10.1093/humrep/dei146. View

13.

Park J, Lee J, Kim M, Chang H, Hwang K, Chang K . Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril. 2009; 92(4):1246-1249. DOI: 10.1016/j.fertnstert.2009.04.025. View

14.

Florio P, Reis F, Torres P, Calonaci F, Toti P, Bocchi C . Plasma urocortin levels in the diagnosis of ovarian endometriosis. Obstet Gynecol. 2007; 110(3):594-600. DOI: 10.1097/01.AOG.0000278572.86019.ae. View

15.

Florio P, Torres P, Torricelli M, Toti P, Vale W, Petraglia F . Human endometrium expresses urocortin II and III messenger RNA and peptides. Fertil Steril. 2006; 86(6):1766-70. DOI: 10.1016/j.fertnstert.2006.05.041. View

16.

Tokmak A, Ugur M, Tonguc E, Var T, Moraloglu O, Ozaksit G . The value of urocortin and Ca-125 in the diagnosis of endometrioma. Arch Gynecol Obstet. 2010; 283(5):1075-9. DOI: 10.1007/s00404-010-1505-2. View

17.

Kahyaoglu I, Kahyaoglu S, Moraloglu O, Zergeroglu S, Sut N, Batioglu S . Comparison of Ki-67 proliferative index between eutopic and ectopic endometrium: a case control study. Taiwan J Obstet Gynecol. 2012; 51(3):393-6. DOI: 10.1016/j.tjog.2012.07.013. View

18.

Bhanoori M, Babu K, Reddy N, Lakshmi Rao K, Zondervan K, Deenadayal M . The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod. 2005; 20(7):1844-9. DOI: 10.1093/humrep/deh852. View

19.

Hao Z, Huang Y, Cleman J, Jovin I, Vale W, Bale T . Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proc Natl Acad Sci U S A. 2008; 105(10):3939-44. PMC: 2268793. DOI: 10.1073/pnas.0712366105. View

20.

Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P . Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol. 1998; 275(5):E757-62. DOI: 10.1152/ajpendo.1998.275.5.E757. View